1007: Policy Changes in Substance Use Disorders and Access to Treatment Impacting Prescribers
Select a Webinar Format:
 On-Demand Audio Recording
       $0.00 for APNA Members
       $0.00 for Non-Members

 
In order to register, you must log in. Use the login form at the top of the left-hand column.

1007: Policy Changes in Substance Use Disorders and Access to Treatment Impacting Prescribers

 

Speaker: David K. Mineta – Deputy Director of Demand Reduction, Office of National Drug Control Policy

 

Disclosures: Discussion of off-label uses will not take place during this presentation.  The speaker and the activity planners have no conflicts of interest to disclose.

 

Session Length: 90 minutes


Target Audience: RN, APRN

 

Session Objectives
Upon completion of this presentation, the participant will be able to:

1. Discuss an overview of the National Drug Control Strategy’s focus on prevention, early intervention, treatment, and recovery.
2. Describe the role psychiatric nurse practitioners play in helping achieve the National Drug Control Strategies.
3. Articulate specific policies that are a part of the National Drug Control Strategy for 1) medication assisted treatment and the new regulations expanding buprenorphine; 2) prescribing practices; 3) overdoes prevention; 4) workforce; and 5) health information technology.  

 

Continuing Nursing Education
1.5 contact hours. * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. We cannot award credit unless all steps are completed.

The content of this CNE activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

 

Originally Presented
Saturday, June 22, 2013 – 8:00am–9:30am
APNA 11th Annual Clinical Psychopharmacology Institute
Reston, Virginia

 

Release Date: August 5, 2013
The contact hours for this session expire: July 31, 2015

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.